Global Botulism Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 121 pages | ID: GA0398E0AD2EN
GlobalInfoResearch

Abstracts

Botulism is a type of poisoning or infection caused by certain bacteria on the preserved food material.

Scope of the Report:

The overall botulism market also provides a detailed analysis of the type and treatment in various regions which includes Americas, Europe, Asia Pacific and Rest of the World. Americas lead the botulism market owing to the largest number of botulism cases every year.

The global Botulism Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Botulism Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Botulism Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Botulism Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

• XOMA (U.S.)
• Microbiotix (U.S.)
• Valeant Pharmaceuticals (Canada)
• Morphotek (U.S.)
• Medytox Solutions (U.S.)
• Lanzhou Institute of Biological Products (China)
• Mentor Corporation and Metabiologics (U.S.)
• Merz Pharma (Germany)
• Allergan (Irish)
• Galderma (Switzerland)

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Antitoxin
• Antibiotics
• Others

Market Segment by Applications, can be divided into

• Hospitals and Clinics
• Others

Contents

1 BOTULISM TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Botulism Treatment
1.2 Classification of Botulism Treatment by Types
  1.2.1 Global Botulism Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Botulism Treatment Revenue Market Share by Types in 2017
  1.2.3 Antitoxin
  1.2.4 Antibiotics
  1.2.5 Others
1.3 Global Botulism Treatment Market by Application
  1.3.1 Global Botulism Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals and Clinics
  1.3.3 Others
1.4 Global Botulism Treatment Market by Regions
  1.4.1 Global Botulism Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Botulism Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Botulism Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Botulism Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Botulism Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Botulism Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Botulism Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 XOMA (U.S.)
  2.1.1 Business Overview
  2.1.2 Botulism Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 XOMA (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Microbiotix (U.S.)
  2.2.1 Business Overview
  2.2.2 Botulism Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Microbiotix (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Valeant Pharmaceuticals (Canada)
  2.3.1 Business Overview
  2.3.2 Botulism Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Valeant Pharmaceuticals (Canada) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Morphotek (U.S.)
  2.4.1 Business Overview
  2.4.2 Botulism Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Morphotek (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Medytox Solutions (U.S.)
  2.5.1 Business Overview
  2.5.2 Botulism Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Medytox Solutions (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lanzhou Institute of Biological Products (China)
  2.6.1 Business Overview
  2.6.2 Botulism Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Lanzhou Institute of Biological Products (China) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Mentor Corporation and Metabiologics (U.S.)
  2.7.1 Business Overview
  2.7.2 Botulism Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Mentor Corporation and Metabiologics (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merz Pharma (Germany)
  2.8.1 Business Overview
  2.8.2 Botulism Treatment Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Merz Pharma (Germany) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Allergan (Irish)
  2.9.1 Business Overview
  2.9.2 Botulism Treatment Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Allergan (Irish) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Galderma (Switzerland)
  2.10.1 Business Overview
  2.10.2 Botulism Treatment Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Galderma (Switzerland) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BOTULISM TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Botulism Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Botulism Treatment Players Market Share
  3.2.2 Top 10 Botulism Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL BOTULISM TREATMENT MARKET SIZE BY REGIONS

4.1 Global Botulism Treatment Revenue and Market Share by Regions
4.2 North America Botulism Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Botulism Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Botulism Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Botulism Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Botulism Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA BOTULISM TREATMENT REVENUE BY COUNTRIES

5.1 North America Botulism Treatment Revenue by Countries (2013-2018)
5.2 USA Botulism Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Botulism Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Botulism Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE BOTULISM TREATMENT REVENUE BY COUNTRIES

6.1 Europe Botulism Treatment Revenue by Countries (2013-2018)
6.2 Germany Botulism Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Botulism Treatment Revenue and Growth Rate (2013-2018)
6.4 France Botulism Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Botulism Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Botulism Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC BOTULISM TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Botulism Treatment Revenue by Countries (2013-2018)
7.2 China Botulism Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Botulism Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Botulism Treatment Revenue and Growth Rate (2013-2018)
7.5 India Botulism Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Botulism Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA BOTULISM TREATMENT REVENUE BY COUNTRIES

8.1 South America Botulism Treatment Revenue by Countries (2013-2018)
8.2 Brazil Botulism Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Botulism Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Botulism Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE BOTULISM TREATMENT BY COUNTRIES

9.1 Middle East and Africa Botulism Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Botulism Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Botulism Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Botulism Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Botulism Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Botulism Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL BOTULISM TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Botulism Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Botulism Treatment Market Forecast by Type (2018-2023)
10.3 Antitoxin Revenue Growth Rate (2013-2023)
10.4 Antibiotics Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)

11 GLOBAL BOTULISM TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Botulism Treatment Revenue Market Share by Application (2013-2018)
11.2 Botulism Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Others Revenue Growth (2013-2018)

12 GLOBAL BOTULISM TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Botulism Treatment Market Size Forecast (2018-2023)
12.2 Global Botulism Treatment Market Forecast by Regions (2018-2023)
12.3 North America Botulism Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Botulism Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Botulism Treatment Revenue Market Forecast (2018-2023)
12.6 South America Botulism Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Botulism Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Botulism Treatment Picture
Table Product Specifications of Botulism Treatment
Table Global Botulism Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Botulism Treatment Revenue Market Share by Types in 2017
Figure Antitoxin Picture
Figure Antibiotics Picture
Figure Others Picture
Table Global Botulism Treatment Revenue (Million USD) by Application (2013-2023)
Figure Botulism Treatment Revenue Market Share by Applications in 2017
Figure Hospitals and Clinics Picture
Figure Others Picture
Table Global Market Botulism Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Botulism Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Botulism Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Botulism Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Botulism Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Botulism Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Botulism Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table XOMA (U.S.) Basic Information, Manufacturing Base and Competitors
Table XOMA (U.S.) Botulism Treatment Type and Applications
Table XOMA (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Microbiotix (U.S.) Basic Information, Manufacturing Base and Competitors
Table Microbiotix (U.S.) Botulism Treatment Type and Applications
Table Microbiotix (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharmaceuticals (Canada) Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals (Canada) Botulism Treatment Type and Applications
Table Valeant Pharmaceuticals (Canada) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Morphotek (U.S.) Basic Information, Manufacturing Base and Competitors
Table Morphotek (U.S.) Botulism Treatment Type and Applications
Table Morphotek (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Medytox Solutions (U.S.) Basic Information, Manufacturing Base and Competitors
Table Medytox Solutions (U.S.) Botulism Treatment Type and Applications
Table Medytox Solutions (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Lanzhou Institute of Biological Products (China) Basic Information, Manufacturing Base and Competitors
Table Lanzhou Institute of Biological Products (China) Botulism Treatment Type and Applications
Table Lanzhou Institute of Biological Products (China) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Mentor Corporation and Metabiologics (U.S.) Basic Information, Manufacturing Base and Competitors
Table Mentor Corporation and Metabiologics (U.S.) Botulism Treatment Type and Applications
Table Mentor Corporation and Metabiologics (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merz Pharma (Germany) Basic Information, Manufacturing Base and Competitors
Table Merz Pharma (Germany) Botulism Treatment Type and Applications
Table Merz Pharma (Germany) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan (Irish) Basic Information, Manufacturing Base and Competitors
Table Allergan (Irish) Botulism Treatment Type and Applications
Table Allergan (Irish) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Galderma (Switzerland) Basic Information, Manufacturing Base and Competitors
Table Galderma (Switzerland) Botulism Treatment Type and Applications
Table Galderma (Switzerland) Botulism Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Botulism Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Botulism Treatment Revenue Share by Players (2013-2018)
Figure Global Botulism Treatment Revenue Share by Players in 2016
Figure Global Botulism Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Botulism Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Botulism Treatment Revenue Market Share in 2017
Figure Global Botulism Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Botulism Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Botulism Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Botulism Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Botulism Treatment Revenue Market Share by Regions in 2017
Figure North America Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure South America Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Botulism Treatment Revenue and Growth Rate (2013-2018)
Table North America Botulism Treatment Revenue by Countries (2013-2018)
Table North America Botulism Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Botulism Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Botulism Treatment Revenue Market Share by Countries in 2017
Figure USA Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Botulism Treatment Revenue and Growth Rate (2013-2018)
Table Europe Botulism Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Botulism Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Botulism Treatment Revenue Market Share by Countries in 2017
Figure Germany Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure UK Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure France Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Botulism Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Botulism Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Botulism Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Botulism Treatment Revenue Market Share by Countries in 2017
Figure China Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure India Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Botulism Treatment Revenue and Growth Rate (2013-2018)
Table South America Botulism Treatment Revenue by Countries (2013-2018)
Table South America Botulism Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Botulism Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Botulism Treatment Revenue Market Share by Countries in 2017
Figure Brazil Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Botulism Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Botulism Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Botulism Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Botulism Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Botulism Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Botulism Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Botulism Treatment Revenue and Growth Rate (2013-2018)
Table Global Botulism Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Botulism Treatment Revenue Share by Type (2013-2018)
Figure Global Botulism Treatment Revenue Share by Type (2013-2018)
Figure Global Botulism Treatment Revenue Share by Type in 2017
Table Global Botulism Treatment Revenue Forecast by Type (2018-2023)
Figure Global Botulism Treatment Market Share Forecast by Type (2018-2023)
Figure Global Antitoxin Revenue Growth Rate (2013-2018)
Figure Global Antibiotics Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Botulism Treatment Revenue by Application (2013-2018)
Table Global Botulism Treatment Revenue Share by Application (2013-2018)
Figure Global Botulism Treatment Revenue Share by Application (2013-2018)
Figure Global Botulism Treatment Revenue Share by Application in 2017
Table Global Botulism Treatment Revenue Forecast by Application (2018-2023)
Figure Global Botulism Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals and Clinics Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Botulism Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Botulism Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Botulism Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Botulism Treatment Revenue Market Forecast (2018-2023)
Figure Europe Botulism Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Botulism Treatment Revenue Market Forecast (2018-2023)
Figure South America Botulism Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Botulism Treatment Revenue Market Forecast (2018-2023)